Antimicrobial resistance and characterization of Helicobacter pylori strains isolated from Mexican adults with clinical outcome

Journal of Chemotherapy

Volumn 17, Issue 3, 2005, Pages 270-276

  Chihu, L ^a,b   Ayala, Guadalupe ^a,c   Mohar, A ^a   Hernandez, A ^a   Herrera Goepfert, R ^a   Fierros, G ^a   Gonzalez Marquez H ^b   Silva, J ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Amoxicillin; Antimicrobial resistance; Clarithromycin; Gastric diseases; Helicobacter pylori; Metronidazole; Virulence factors

Indexed keywords

AMOXICILLIN; CAGA PROTEIN; CLARITHROMYCIN; METRONIDAZOLE; RIBOSOME RNA; VACUOLATING TOXIN;

ADULT; AGED; ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; CHRONIC GASTRITIS; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; LYMPH FOLLICLE; MAJOR CLINICAL STUDY; MALE; MEXICO; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEQUENCE ANALYSIS; STOMACH BIOPSY; STOMACH CANCER;

EID: 22244484765     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.3.270     Document Type: Article

References (37)

1. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61:1-241.
2. Bardhan PK. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis 1997; 25(5):973-978.
3. Graham DY, Adam E, Reddy GT et al. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci 1991; 36(8):1084-1088.
4. Mitchell HM, Li YY, Hu PJ et al. Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition. J Infect Dis 1992; 166(1):149-153.
5. Perez-Perez GI, Taylor DN, Bodhidatta L et al. Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis 1990; 161(6):1237-1241.
6. Torres J, Leal-Herrera Y, Perez-Perez G et al. A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico. J Infect Dis 1998; 178(4):1089-1094.
7. Lopez-Carrillo L, Lopez-Cervantes M, Robles-Diaz G et al. Capsaicin consumption, Helicobacter pylori positivity and gastric cancer in Mexico. Int J Cancer 2003; 106(2):277-282.
8. de Boer WA, Tytgat GN. Regular review: treatment of Helicobacter pylori infection. BMJ 2000; 320(7226):31-34.
9. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995; 333(15):984-991.
10. Bazzoli F. Key points from the revised Maastricht Consensus Report: the impact on general practice. Eur J Gastroenterol Hepatol 2001; 13 Suppl 2:S3-S7.
11. de Wit NJ, Mendive J, Seifert B, Cardin F, Rubin G. Guidelines on the management of H. pylori in primary care: development of an implementation strategy. Fam Pract 2000; 17 Suppl 2:S27-S32.
12. Hunt RH, Fallone CA, Thomson AB. Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group. Can J Gastroenterol 1999; 13(3):213-217.
13. Sherman P, Hassall E, Hunt RH, Fallone CA, Veldhuyzen VZ, Thomson AB. Canadian Helicobacter Study Group Consensus Conference on the Approach to Helicobacter pylori Infection in Children and Adolescents. Can J Gastroenterol 1999; 13(7):553-559.
14. Kato S, Fujimura S, Udagawa H et al. Antibiotic resistance of Helicobacter pylori strains in Japanese children. J Clin Microbiol 2002; 40(2):649-653.
15. Adamek RJ, Suerbaum S, Pfaffenbach B, Opferkuch W. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin-influence on treatment outcome. Am J Gastroenterol 1998; 93(3):386-389.
16. Gotoh A, Kawakami Y, Akahane T et al. Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy. Microbiol Immunol 1997; 41(1):7-12.
17. Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998; 115(5):1272-1277.
18. Debets-Ossenkopp YJ, Reyes G, Mulder J et al. Characteristics of clinical Helicobacter pylori strains from Ecuador. J Antimicrob Chemother 2003; 51(1):141-145.
19. Megraud F. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 1998; 115(5):1278-1282.
20. Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11 Suppl 1:43-53.
21. Megraud F, Lehn N, Lind T et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 1999; 43(11):2747-2752.
22. Ryan KA, van Doom LJ, Moran AP, Glennon M, Smith T, Maher M. Evaluation of clarithromycin resistance and cagA and vacA genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays. J Clin Microbiol 2001; 39(5):1978-1980.
23. Torres J, Camorlinga-Ponce M, Perez-Perez G et al. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J Clin Microbiol 2001; 39(7):2677-2680.
24. Garza-Gonzalez E, Perez-Perez GI, Alanis-Aguilar O, Tijerina-Menchaca R, Maldonado-Garza HJ, Bosques-Padilla FJ. Antibiotic susceptibility patterns of Helicobacter pylori strains isolated from northeastern Mexico. J Chemother 2002; 14(4):342-345.
25. Burucoa C, Lhomme V, Fauchere JL. Performance criteria of DNA fingerprinting methods for typing of Helicobacter pylori isolates: experimental results and meta-analysis. J Clin Microbiol 1999; 37(12):4071-4080.
26. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20(10):1161-1181.
27. Laur'en P. The two histological main types of gastric carcinoma diffuse and so-calles intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
28. Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17(12):3835-3849.
29. Engstrand L, Nguyen AM, Graham DY, el Zaatari FA. Reverse transcription and polymerase chain reaction amplification of rRNA for detection of Helicobacter species. J Clin Microbiol 1992; 30(9):2295-2301.
30. Atherton JC, Cao P, Peek RM, Jr., Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270(30):17771-17777.
31. Glupczynski Y, Labbe M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol 1991; 29(9):2072-2075.
32. Fontana C, Favaro M, Minelli S et al. New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob Agents Chemother 2002; 46(12):3765-3769.
33. Fontana C, Favaro M, Pietroiusti A, Pistoia ES, Galante A, Favalli C. Detection of clarithromycin-resistant Helicobacter pylori in stool samples. J Clin Microbiol 2003; 41(8):3636-3640.
34. Broutet N, Marais A, Lamouliatte H et al. cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia. J Clin Microbiol 2001; 39(4): 1319-1322.
35. van Doorn LJ, Schneeberger PM, Nouhan N, Plaisier AP, Quint WG, de Boer WA. Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut 2000; 46(3):321-326.
36. Lui SY, Yeoh KG, Ho B. Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population. J Clin Microbiol 2003; 41(11):5011-5014.
37. Herrera-Goepfert R, Arista-Nasr J, Alba-Campomanes A. Pathologic features of the gastric mucosa adjacent to primary MALT-lymphomas. J Clin Gastroenterol 1999; 29(3):266-269.